O. Lebeda

2.5k total citations
69 papers, 1.2k citations indexed

About

O. Lebeda is a scholar working on Radiology, Nuclear Medicine and Imaging, Radiation and Nuclear and High Energy Physics. According to data from OpenAlex, O. Lebeda has authored 69 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Radiology, Nuclear Medicine and Imaging, 30 papers in Radiation and 19 papers in Nuclear and High Energy Physics. Recurrent topics in O. Lebeda's work include Radiopharmaceutical Chemistry and Applications (37 papers), Nuclear Physics and Applications (19 papers) and Medical Imaging Techniques and Applications (14 papers). O. Lebeda is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (37 papers), Nuclear Physics and Applications (19 papers) and Medical Imaging Techniques and Applications (14 papers). O. Lebeda collaborates with scholars based in Czechia, Germany and Russia. O. Lebeda's co-authors include Jan Štursa, Jan Kučka, Marek Pruszyński, Martin Hrubý, R. Capote, Ján Kozempel, F. G. Kondev, Jan Ráliš, T. Kibédi and B. V. Carlson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Journal of Controlled Release.

In The Last Decade

O. Lebeda

64 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Lebeda Czechia 21 692 425 298 259 228 69 1.2k
Federica Simonelli Italy 21 435 0.6× 241 0.6× 80 0.3× 94 0.4× 199 0.9× 49 1.0k
L.F. Mausner United States 23 1.1k 1.5× 480 1.1× 149 0.5× 160 0.6× 475 2.1× 78 1.5k
Christiaan Vermeulen South Africa 18 737 1.1× 323 0.8× 162 0.5× 164 0.6× 326 1.4× 58 1.0k
S. Altieri Italy 26 1.2k 1.8× 868 2.0× 236 0.8× 42 0.2× 383 1.7× 134 2.0k
Paul A. Ellison United States 23 584 0.8× 164 0.4× 405 1.4× 75 0.3× 244 1.1× 60 1.7k
R. A. Boll United States 14 693 1.0× 197 0.5× 102 0.3× 41 0.2× 294 1.3× 34 1.1k
F.M. Nortier United States 26 1.2k 1.8× 895 2.1× 480 1.6× 508 2.0× 479 2.1× 84 2.1k
G.J. Beyer Germany 17 611 0.9× 228 0.5× 109 0.4× 104 0.4× 242 1.1× 54 967
F. Szelecsényi Hungary 25 1.3k 1.8× 953 2.2× 497 1.7× 484 1.9× 335 1.5× 80 1.8k
G. Blessing Germany 15 563 0.8× 312 0.7× 120 0.4× 117 0.5× 151 0.7× 22 772

Countries citing papers authored by O. Lebeda

Since Specialization
Citations

This map shows the geographic impact of O. Lebeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Lebeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Lebeda more than expected).

Fields of papers citing papers by O. Lebeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Lebeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Lebeda. The network helps show where O. Lebeda may publish in the future.

Co-authorship network of co-authors of O. Lebeda

This figure shows the co-authorship network connecting the top 25 collaborators of O. Lebeda. A scholar is included among the top collaborators of O. Lebeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Lebeda. O. Lebeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebeda, O., et al.. (2025). Cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production. Nuclear Medicine and Biology. 142-143. 108995–108995.
2.
Duval, M.-A., et al.. (2024). First production of pure 155Gd targets and 155Gd(p,x)155Tb, 156Tb cross-section measurements. Applied Radiation and Isotopes. 213. 111485–111485. 1 indexed citations
3.
Košťál, Michal, O. Lebeda, Václav Zach, et al.. (2024). Measurement of secondary neutron spectra and the total yield from 18O(p,xn) reaction. Radiation Physics and Chemistry. 229. 112431–112431. 1 indexed citations
4.
Košťál, Michal, Jan Šimon, M. Majerle, et al.. (2023). Characterization of the secondary neutron field inside a cyclotron for production of radiopharmaceuticals. Applied Radiation and Isotopes. 199. 110865–110865. 4 indexed citations
5.
Šefčík, M., et al.. (2023). Gamma-ray energies and intensities observed in decay chain 83Rb/83mKr/83Kr. The European Physical Journal A. 59(4). 1 indexed citations
6.
Ullrich, Martin, Kristof Zarschler, O. Lebeda, et al.. (2021). Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics. ChemMedChem. 16(17). 2645–2649. 7 indexed citations
7.
Vlk, Martin, et al.. (2021). Simple new method for labelling of PSMA-11 with 68Ga in NaHCO3. Applied Radiation and Isotopes. 172. 109692–109692. 7 indexed citations
8.
Lebeda, O., Jan Ráliš, & Jan Štursa. (2019). Excitation functions of the 165Ho(3He,xn)166,165,163Tm and natTi(3He,x)48V,48Cr reactions. Applied Radiation and Isotopes. 156. 108988–108988. 3 indexed citations
9.
Ráliš, Jan, Irena Sieglová, Vlastimil Král, et al.. (2018). Radiolabeling of the antibody IgG M75 for epitope of human carbonic anhydrase IX by 61Cu and 64Cu and its biological testing. Applied Radiation and Isotopes. 143. 87–97. 9 indexed citations
10.
Ráliš, Jan, et al.. (2017). In vitro evaluation of the monoclonal antibody 64Cu-IgG M75 against human carbonic anhydrase IX and its in vivo imaging. Applied Radiation and Isotopes. 133. 9–13. 10 indexed citations
11.
Beckford-Vera, Denis, Marco Fellner, Natalia S. Loktionova, et al.. (2012). Imaging of Protein Synthesis: In Vitro and In Vivo Evaluation of 44Sc-DOTA-Puromycin. Molecular Imaging and Biology. 15(1). 79–86. 31 indexed citations
12.
Beckford-Vera, Denis, Marco Fellner, Natalia S. Loktionova, et al.. (2012). Measurement of Protein Synthesis: In Vitro Comparison of 68Ga-DOTA-Puromycin, [3H]Tyrosine, and 2-Fluoro-[3H]tyrosine. Recent results in cancer research. 194. 269–283. 4 indexed citations
13.
Hrubý, Martin, P Poučková, M Zadinová, Jan Kučka, & O. Lebeda. (2011). Thermoresponsive polymeric radionuclide delivery system—An injectable brachytherapy. European Journal of Pharmaceutical Sciences. 42(5). 484–488. 28 indexed citations
14.
Beckford-Vera, Denis, et al.. (2011). Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors. Nuclear Medicine and Biology. 39(1). 3–13. 35 indexed citations
15.
Lebeda, O., et al.. (2010). New measurement of excitation functions for (d,x) reactions on natMo with special regard to the formation of 95mTc, 96m+gTc, 99mTc and 99Mo. Applied Radiation and Isotopes. 68(12). 2425–2432. 41 indexed citations
16.
Lebeda, O. & Marek Pruszyński. (2010). New measurement of excitation functions for (p,x) reactions on natMo with special regard to the formation of 95mTc, 96m+gTc, 99mTc and 99Mo. Applied Radiation and Isotopes. 68(12). 2355–2365. 65 indexed citations
17.
Kučka, Jan, Martin Hrubý, & O. Lebeda. (2010). Biodistribution of a radiolabelled thermoresponsive polymer in mice. Applied Radiation and Isotopes. 68(6). 1073–1078. 16 indexed citations
18.
Hrubý, Martin, Jan Kučka, O. Lebeda, et al.. (2007). New bioerodable thermoresponsive polymers for possible radiotherapeutic applications. Journal of Controlled Release. 119(1). 25–33. 43 indexed citations
19.
Lebeda, O., et al.. (2005). A new internal target system for production of 211At on the cyclotron U-120M. Applied Radiation and Isotopes. 63(1). 49–53. 32 indexed citations
20.
Orlova, Anna, Mark Lubberink, O. Lebeda, et al.. (2002). Comparative Biodistribution of the Radiohalogenated (Br, I and At) Antibody A33. Implications for In Vivo Dosimetry.. Cancer Biotherapy and Radiopharmaceuticals. 17(4). 385–396. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026